03.28.2025 Pfizer Pflash: A Spotlight on IRA Part D Redesign and its Impact in 2025 Presentation(opens in new window) Transcript(opens in new window) Webcast(opens in new window) 03.03.2025 TD Cowen 45th Annual Health Care Conference ...
I am a whistleblower suing Pfizer and my former employer, Ventavia Research Group, in Federal court under the False Claims Act for fraud I witnessed during the Pfizer COVID-19 MRNA clinical trials in September 2020. I have dedicated nearly two decades of my career to ensuring the ...
Corporate Governance Documents Board Policies Corporate Governance FAQs Contact Our Directors More Resources Shareholder Services Shareholder Services Overview Pfizer Investor Insights Stock FAQs Cost Basis Calculator Science Clinical Trials Guide to Clinical TrialsYour participation makes a difference Clinical Trial...
02.04.2025 Pfizer Quarterly Corporate Performance - Fourth Quarter 2024 Press Release(opens in new window) Presentation(opens in new window) Prepared Remarks(opens in new window) Infographic(opens in new window) Transcript(opens in new window) ...
Pfizer's Covid-19 vaccine was 90.7% effective in 5 to 11 year olds in clinical trials, according to new FDA documents. CNBC's Meg Tirrell reports. Fri, Oct 22 20219:24 AM EDTwatch now watch now VIDEO04:59 J.P. Morgan's David Kelly: Consumer sentiment data isn'...
view to aspects of the clinical trial process. This is best illus- The growth in EU member states has carried with it the trated by the variations in clinical trial approval procedures and integration of EMEA regulations governing clinical trials, required documents described in the report for ...
Methods: data collection was carried out through the use of boolean searches on the Pubmed and Google Scholar search engines, in order to filter all published randomized clinical trials for each vaccine, following the recommendations of GRADE in relation to the level of eviden...
“Sublicensee”); provided, however, that, prior to the payment of the first milestone pursuant to Section 7.2, Licensee may not grant any such sublicense to any contract research organization conducting Clinical Trials of Products or any Third Parties conducting contract Manufacturing activities ...
In June 2020, Pfizer announced the initiation of two Phase 3 clinical trials (NCT04382326 and NCT04379713) evaluating a four-dose series in infants starting at 2 months of age. Both studies will expand the data on the safety and tolerability of the investigational vaccine in infants and include...
The documents were released on Tuesday (Dec. 8), two days before a meeting of the FDA's vaccine advisory panel, which will vote on whether to recommend authorization of the vaccine in the U.S. The FDA analyzed data from Pfizer's phase 3 clinical trial, which included some 44,000 people...